Plain-English translation of NCT07203287 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
During surgery, doctors use medications to relax your muscles so they can safely operate. This trial compares two different muscle-relaxing medications— and —to see which one is safer for people with chronic kidney disease, especially when it comes to breathing problems after surgery. You would be randomly assigned to receive one of these two treatments, both of which are already standard practice in operating rooms.
People with kidney disease may process medications differently than others, which could affect how well the medication works and how safely they recover after surgery. This trial aims to find out which of these two commonly used medications leads to fewer breathing complications after surgery in this population.
You likely qualify if…
You likely don't qualify if…
You would have your surgery as planned, and during the operation, you would receive one of the two muscle-relaxing medications (chosen randomly). After surgery, doctors and nurses would watch you closely for up to 7 days, checking for any breathing problems such as pneumonia, low oxygen levels, or trouble breathing. You would be monitored as part of your normal post-surgery care—no extra visits or tests beyond what is standard.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States